Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2015 1
2019 1
2020 2
2021 1
2022 1
2023 4
2024 6
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Stromal Keratitis in the Zoster Eye Disease Study: Lessons Learned.
Jacobs DS, Lee T, Asbell P, Shen J, Choulakian M, Holland GN, Baratz KH, Prescott CR, Colby K, Hochman JS, Troxel AB, Cohen E, Jeng BH. Jacobs DS, et al. Am J Ophthalmol. 2026 May;285:144-151. doi: 10.1016/j.ajo.2026.01.034. Epub 2026 Feb 6. Am J Ophthalmol. 2026. PMID: 41655829 Clinical Trial.
PURPOSE: To report on the presentation, treatment, and visual outcome of stromal keratitis (SK) in the Zoster Eye Disease Study (ZEDS). DESIGN: Secondary analysis of SK end point of randomized clinical trial. SUBJECTS: Patients with herpes zoster ophthalmicus (HZO) were ra …
PURPOSE: To report on the presentation, treatment, and visual outcome of stromal keratitis (SK) in the Zoster Eye Disease Study (ZEDS …
Analysis of the Zoster Eye Disease Study Using Original End Point Criteria.
Jeng BH, Jacobs DS, Lee TF, Troxel AB, Liu M, Colby KA, Kim J, Hochman JS, Cohen EJ; ZEDS Trial Research Group. Jeng BH, et al. Ophthalmology. 2026 Mar;133(3):423-424. doi: 10.1016/j.ophtha.2025.10.018. Epub 2025 Oct 28. Ophthalmology. 2026. PMID: 41167530 Free article. No abstract available.
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial.
Warner DB, Jeng BH, Kim J, Liu M, Troxel AB, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Meyer JJ, Lu Y, Twi-Yeboah A, Lee TF, Lopez-Jimenez C, Laury SC, Cohen EJ; ZEDS Trial Research Group. Warner DB, et al. JAMA Ophthalmol. 2025 Apr 1;143(4):277-285. doi: 10.1001/jamaophthalmol.2024.6113. JAMA Ophthalmol. 2025. PMID: 40048191 Free PMC article. Clinical Trial.
Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial.
Cohen EJ, Troxel AB, Liu M, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Warner DB, Lu Y, Twi-Yeboah A, Lee TF, Kim J, Lopez-Jimenez C, Laury SC, Jeng BH; ZEDS Trial Research Group. Cohen EJ, et al. JAMA Ophthalmol. 2025 Apr 1;143(4):269-276. doi: 10.1001/jamaophthalmol.2024.6114. JAMA Ophthalmol. 2025. PMID: 40048183 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The Zoster Eye Disease Study (ZEDS) was a randomized clinical trial conducted in 95 sites from November 2017 to June 2024. ...
DESIGN, SETTING, AND PARTICIPANTS: The Zoster Eye Disease Study (ZEDS) was a randomized clinical trial conducted in 95 sites from Nov …
Recruitment Strategies and Obstacles During the Zoster Eye Disease Study.
Sherman MD, Asbell P, Warner D, Mian SI, Cohen E, Lee TF, Gillespie C, Jimenez CL, Baratz KH, Jeng B. Sherman MD, et al. Cornea. 2024 Dec 3;44(9):1101-1106. doi: 10.1097/ICO.0000000000003762. Cornea. 2024. PMID: 39625123
PURPOSE: The aim of this study was to identify successful recruitment strategies and obstacles reported by principal investigators (PIs) of the Zoster Eye Disease Study (ZEDS). METHODS: A web-based survey was created by a subset of ZEDS PIs and distributed to ZED …
PURPOSE: The aim of this study was to identify successful recruitment strategies and obstacles reported by principal investigators (PIs) of …
Baseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study.
Prescott CR, Cohen EJ, Hochman JS, Troxel AB, Lu Y, Twi-Yeboah A, Jimenez CL, Mian SI, Mazen CY, Warner DB, Baratz KH, Jeng BH; ZEDS Trial Research Group. Prescott CR, et al. Cornea. 2024 Dec 1;43(12):1473-1480. doi: 10.1097/ICO.0000000000003497. Cornea. 2024. PMID: 38411973 Free PMC article. Clinical Trial.
PURPOSE: The Zoster Eye Disease Study (ZEDS) is the first randomized clinical trial to study the efficacy of long-term (1 year) suppressive valacyclovir treatment on herpes zoster ophthalmicus (HZO) outcomes. ...Most participants were treated acutely with a recommended ant …
PURPOSE: The Zoster Eye Disease Study (ZEDS) is the first randomized clinical trial to study the efficacy of long-term (1 year) suppr …
Characteristics of Prescreened Patients Who Did Not Participate in the Zoster Eye Disease Study.
Maja AK, Gu D, Ge L, Lopez-Jimenez C, Cohen EJ, Zegans ME. Maja AK, et al. Eye Contact Lens. 2024 Jul 1;50(7):311-314. doi: 10.1097/ICL.0000000000001098. Epub 2024 May 9. Eye Contact Lens. 2024. PMID: 38722254 Free PMC article. Clinical Trial.
Among the 12 exclusion criteria for the ZEDS study, immunocompromise (76/296, 25.7%) and renal insufficiency (50/296, 16.9%) were most frequently reported. ...There may be benefits to long-term antiviral use in these populations not captured in ZEDS. A quarter (26.3 …
Among the 12 exclusion criteria for the ZEDS study, immunocompromise (76/296, 25.7%) and renal insufficiency (50/296, 16.9%) were mos …
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Narro GEC, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. Rinella ME, et al. Ann Hepatol. 2024 Jan-Feb;29(1):101133. doi: 10.1016/j.aohep.2023.101133. Epub 2023 Jun 24. Ann Hepatol. 2024. PMID: 37364816 Free article. Review.
19 results